Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximing Xu

Showing results (31-40 of 467) with videos related to

Pageof 47
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 31, 2026
Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategiesXiaohong Liu, Daoming Zhang, Le Xu, et al.
Cancer Medicine|September 2, 2021
Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarkerXinyao Hu, Hua Zhu, Xiaoyu Zhang, et al.
Tissue Engineering. Part B, Reviews|September 10, 2025
Botanical Nanovesicles Boost Mesenchymal Stem Cell Therapy: Next-Gen Advanced Therapy Medicinal Products for Spinal Cord InjuryZhe Wang, Wenwen Deng, Qingtong Yu, et al.
Journal of the Science of Food and Agriculture|February 22, 2013
Comparison of acid degumming and enzymatic degumming process for Silybum marianum seed oilLin Mei, Liang Wang, Qianqian Li, et al.
Food Research International (Ottawa, Ont.)|September 7, 2017
Quercetin as a tyrosinase inhibitor: Inhibitory activity, conformational change and mechanismMeihui Fan, Guowen Zhang, Xing Hu, et al.
Therapeutic Advances in Medical Oncology|January 11, 2021
The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysisHuilin Xu, Ximing Xu, Wei Ge, et al.
Oncoimmunology|August 21, 2019
High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patientsDedong Cao, Huilin Xu, Ximing Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 24, 2024
Copper homeostasis and cuproptosis in radiation-induced injuryDaoming Zhang, Yuan Li, Jinghui Pan, et al.
Angewandte Chemie (International Ed. in English)|July 8, 2024
Engineered Cellular Vesicles Displaying Glycosylated Nanobodies for Cancer ImmunotherapyJicheng Wu, Hailin Lu, Ximing Xu, et al.
BMC Infectious Diseases|December 15, 2023
A hybrid model for hand-foot-mouth disease prediction based on ARIMA-EEMD-LSTMYiran Wan, Ping Song, Jiangchen Liu, et al.
Pageof 47

Showing results (31-40 of 467) with videos related to

Sort By:
Pageof 47
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 31, 2026
Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategiesXiaohong Liu, Daoming Zhang, Le Xu, et al.
Cancer Medicine|September 2, 2021
Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarkerXinyao Hu, Hua Zhu, Xiaoyu Zhang, et al.
Tissue Engineering. Part B, Reviews|September 10, 2025
Botanical Nanovesicles Boost Mesenchymal Stem Cell Therapy: Next-Gen Advanced Therapy Medicinal Products for Spinal Cord InjuryZhe Wang, Wenwen Deng, Qingtong Yu, et al.
Journal of the Science of Food and Agriculture|February 22, 2013
Comparison of acid degumming and enzymatic degumming process for Silybum marianum seed oilLin Mei, Liang Wang, Qianqian Li, et al.
Food Research International (Ottawa, Ont.)|September 7, 2017
Quercetin as a tyrosinase inhibitor: Inhibitory activity, conformational change and mechanismMeihui Fan, Guowen Zhang, Xing Hu, et al.
Therapeutic Advances in Medical Oncology|January 11, 2021
The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysisHuilin Xu, Ximing Xu, Wei Ge, et al.
Oncoimmunology|August 21, 2019
High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patientsDedong Cao, Huilin Xu, Ximing Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 24, 2024
Copper homeostasis and cuproptosis in radiation-induced injuryDaoming Zhang, Yuan Li, Jinghui Pan, et al.
Angewandte Chemie (International Ed. in English)|July 8, 2024
Engineered Cellular Vesicles Displaying Glycosylated Nanobodies for Cancer ImmunotherapyJicheng Wu, Hailin Lu, Ximing Xu, et al.
BMC Infectious Diseases|December 15, 2023
A hybrid model for hand-foot-mouth disease prediction based on ARIMA-EEMD-LSTMYiran Wan, Ping Song, Jiangchen Liu, et al.
Pageof 47